Fertility and Sterility
Volume 91, Issue 3 , Pages 749-766 , March 2009

How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis

Received 8 June 2007 ,Revised 31 December 2007 ,Accepted 31 December 2007.

References 

  1. Surrey ES, Schoolcraft WB. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril. 2000;73:667–676
  2. Jenkins JM, Davies DW, Devonport H, Anthony FW, Gadd SC, Watson RH, et al. Comparison of “poor” responders with “good” responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization. Hum Reprod. 1991;6:918–921
  3. Ben-Rafael Z, Bider D, Dan U, Zolti M, Levran D, Mashiach S. Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMG. J In Vitro Fert Embryo Transf. 1991;8:33–36
  4. Akande VA, Fleming CF, Hunt LP, Keay SD, Jenkins JM. Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment. Hum Reprod. 2002;17:2003–2008
  5. Nargund G, Bromhan D. Comparison of endocrinological and clinical profiles and outcome of IVF cycles in patients with one ovary and two ovaries. J Assist Reprod Genet. 1995;12:458–460
  6. Keay SD, Liversedge NH, Jenkins JM. Could ovarian infection impair ovarian response to gonadotrophin stimulation?. Br J Obstet Gynaecol. 1998;105:252–253
  7. Ragni G, De Lauretis Yankowski L, Piloni S, Vegetti W, Guermandi E, Colombo M, et al. In vitro fertilization for patients with poor response and occult ovarian failure: a randomized trial. Reprod Technol. 2000;10:98–102
  8. Loh S, Wang JX, Matthews CD. The influence of body mass index, basal FSH and age on the response to gonadotrophin stimulation in non-polycystic ovarian syndrome patients. Hum Reprod. 2002;17:1207–1211
  9. Keay SD, Liversedge NH, Mathur RS, Jenkins JM. Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol. 1997;104:521–527
  10. Nikolaou D, Templeton A. Early ovarian ageing: a hypothesis. Detection and clinical relevance. Hum Reprod. 2003;18:1137–1139
  11. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update. 2003;9:61–76
  12. Ubaldi FM, Rienzi L, Ferrero S, Baroni E, Sapienza F, Cobellis L, et al. Management of poor responders in IVF. Reprod Biomed Online. 2005;10:235–246
  13. Evers JL. Publication bias in reproductive research. Hum Reprod. 2000;15:2063–2066
  14. Bergh C, Hillensjo T, Wikland M, Nilsson L, Borg G, Hamberger L. Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertil Steril. 1994;62:113–120
  15. Dor J, Seidman DS, Amudai E, Bider D, Levran D, Mashiach S. Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study. Hum Reprod. 1995;10:40–43
  16. Suikkari A, MacLachlan V, Koistinen R, Seppala M, Healy D. Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertil Steril. 1996;65:800–805
  17. Owen EJ, Shoham Z, Mason BA, Ostergaard H, Jacobs HS. Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertil Steril. 1991;56:1104–1110
  18. Zhuang GL, Wong SX, Zhou CQ. [The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer]. Chung-Hua Fu Chan Ko Tsa Chih [Chin J Obstet Gynecol] 510;29:471–4.
  19. Howles CM, Loumaye E, Germond M, Yates R, Brinsden P, Healy D, et al. Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization?. Hum Reprod. 1999;14:1939–1943
  20. Kim CH, Chae HD, Chang YS. Pyridostigmine cotreatment for controlled ovarian hyperstimulation in low responders undergoing in vitro fertilization-embryo transfer. Fertil Steril. 1999;71:652–657
  21. Battaglia C, Salvatori M, Maxia N, Petraglia F, Facchinetti F, Volpe A. Adjuvant l-arginine treatment for in-vitro fertilization in poor responder patients. Hum Reprod. 1999;14:1690–1697
  22. Massin N, Cedrin-Durnerin I, Coussieu C, Galey-Fontaine J, Wolf JP, Hugues JN. Effects of transdermal testosterone application on the ovarian response to fsh in poor responders undergoing assisted reproduction technique—a prospective, randomized, double-blind study. Hum Reprod. 2006;21:1204–1211
  23. Goswami SK, Das T, Chattopadhyay R, Sawhney V, Kumar J, Chaudhury K, et al. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report. Hum Reprod. 2004;19:2031–2035
  24. Weissman A, Farhi J, Royburt M, Nahum H, Glezerman M, Levran D. Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization-embryo transfer. Fertil Steril. 2003;79:886–892
  25. Marci R, Caserta D, Dolo V, Tatone C, Pavan A, Moscarini M. GnRH antagonist in IVF poor-responder patients: results of a randomized trial. Reprod Biomed Online. 2005;11:189–193
  26. D'Amato G, Caroppo E, Pasquadibisceglie A, Carone D, Vitti A, Vizziello GM. A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years. Fertil Steril. 2004;81:1572–1577
  27. Malmusi S, La Marca A, Giulini S, Xella S, Tagliasacchi D, Marsella T, et al. Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation. Fertil Steril. 2005;84:402–406
  28. Schmidt DW, Bremner T, Orris JJ, Maier DB, Benadiva CA, Nulsen JC. A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders. Fertil Steril. 2005;83:1568–1571
  29. Martinez F, Coroleu B, Marques L, Parera N, Buxaderas R, Tur R, et al. Comparison of “short protocol” versus “antagonists” with or without clomiphene citrate for stimulation in IVF of patients with “low response”. Rev Iberoam Fertil Reprod Hum. 2003;20:355–360
  30. Morgia F, Sbracia M, Schimberni M, Giallonardo A, Piscitelli C, Giannini P, et al. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. Fertil Steril. 2004;81:1542–1547
  31. Dirnfeld M, Fruchter O, Yshai D, Lissak A, Ahdut A, Abramovici H. Cessation of gonadotropin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization. Fertil Steril. 1999;72:406–411
  32. Garcia-Velasco JA, Isaza V, Requena A, Martinez-Salazar FJ, Landazabal A, Remohi J, et al. High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial. Hum Reprod. 2000;15:2292–2296
  33. Raga F, Bonilla-Musoles F, Casan EM, Bonilla F. Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome. Hum Reprod. 1999;14:1431–1434
  34. Moreno C, Ruiz A, Simon C, Pellicer A, Remohi J. Intracytoplasmic sperm injection as a routine indication in low responder patients. Hum Reprod. 1998;13:2126–2129
  35. Bahceci M, Ulug U, Ciray HN, Akman MA, Erden HF. Efficiency of changing the embryo transfer time from day 3 to day 2 among women with poor ovarian response: a prospective randomized trial. Fertil Steril. 2006;86:81–85
  36. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685–718
  37. Jia XC, Kalmijn J, Hsueh AJ. Growth hormone enhances follicle-stimulating hormone-induced differentiation of cultured rat granulosa cells. Endocrinology. 1986;118:1401–1409
  38. Doldi N, Bassan M, Bonzi V, Ferrari A. Effects of growth hormone and growth hormone-releasing hormone on steroid synthesis in cultured human luteinizing granulosa cells. Gynecol Endocrinol. 1996;10:101–108
  39. Lanzone A, Di Simone N, Castellani R, Fulghesu AM, Caruso A, Mancuso S. Human growth hormone enhances progesterone production by human luteal cells in vitro: evidence of a synergistic effect with human chorionic gonadotropin. Fertil Steril. 1992;57:92–96
  40. Delitala G, Tomasi P, Virdis R. Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications. J Endocrinol Invest. 1988;11:441–462
  41. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109–142
  42. Anteby EY, Hurwitz A, Korach O, Revel A, Simon A, Finci-Yeheskel Z, et al. Human follicular nitric oxide pathway: relationship to follicular size, oestradiol concentrations and ovarian blood flow. Hum Reprod. 1996;11:1947–1951
  43. Suzuki T, Sasano H, Kimura N, Tamura M, Fukaya T, Yajima A, et al. Immunohistochemical distribution of progesterone, androgen and oestrogen receptors in the human ovary during the menstrual cycle: relationship to expression of steroidogenic enzymes. Hum Reprod. 1994;9:1589–1595
  44. Horie K, Takakura K, Fujiwara H, Suginami H, Liao S, Mori T. Immunohistochemical localization of androgen receptor in the human ovary throughout the menstrual cycle in relation to oestrogen and progesterone receptor expression. Hum Reprod. 1992;7:184–190
  45. Simpson E, Rubin G, Clyne C, Robertson K, O'Donnell L, Jones M, et al. The role of local estrogen biosynthesis in males and females. Trends Endocrinol Metab. 2000;11:184–188
  46. Giudice LC. Insulin-like growth factors and ovarian follicular development. Endocr Rev. 1992;13:641–669
  47. Palter SF, Tavares AB, Hourvitz A, Veldhuis JD, Adashi EY. Are estrogens of import to primate/human ovarian folliculogenesis?. Endocr Rev. 2001;22:389–424
  48. Biljan MM, Hemmings R, Brassard N. The outcome of 150 babies following the treatment with letrozole and gonadotrophins. Fertil Steril. 2005;84:S95
  49. Craft I, Gorgy A, Hill J, Menon D, Podsiadly B. Will GnRH antagonists provide new hope for patients considered “difficult responders” to GnRH agonist protocols?. Hum Reprod. 1999;14:2959–2962
  50. Out HJ, Mannaerts BM, Driessen SG, Coelingh Bennink HJ. Recombinant follicle stimulating hormone (rFSH; Puregon) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies. Hum Reprod Update. 1996;2:162–171

 D.K. has nothing to disclose. E.M.K. has nothing to disclose. C.A.V. has nothing to disclose. E.G.P. has nothing to disclose. J.B. has nothing to disclose. B.C.T. has nothing to disclose.

 We declare that no financial conflict of interest exists with any commercial entity, whose products are described, reviewed, evaluated or compared in this manuscript.

PII: S0015-0282(08)00004-6

doi: 10.1016/j.fertnstert.2007.12.077

Fertility and Sterility
Volume 91, Issue 3 , Pages 749-766 , March 2009

Article Tools

* Image Usage & Resolution